tiprankstipranks
Trending News
More News >
Recce Pharmaceuticals Ltd. (AU:RCE)
ASX:RCE
Australian Market

Recce Pharmaceuticals Ltd. (RCE) Financial Statements

Compare
20 Followers

Recce Pharmaceuticals Ltd. Financial Overview

Recce Pharmaceuticals Ltd.'s market cap is currently AU$203.87M. The company's EPS TTM is AU$-0.057; its P/E ratio is -7.77; Recce Pharmaceuticals Ltd. is scheduled to report earnings on August 29, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueAU$ 7.51MAU$ 5.03MAU$ 4.37MAU$ 3.08MAU$ 1.64M
Gross ProfitAU$ -2.94MAU$ -2.19MAU$ 4.15MAU$ 2.90MAU$ 1.34M
Operating IncomeAU$ -22.88MAU$ -22.05MAU$ -17.33MAU$ -14.15MAU$ -15.36M
EBITDAAU$ -20.33MAU$ -21.35MAU$ -16.99MAU$ -13.87MAU$ -14.77M
Net IncomeAU$ -21.43MAU$ -17.66MAU$ -13.08MAU$ -10.99MAU$ -13.51M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 10.45MAU$ 4.42MAU$ 1.56MAU$ 11.58MAU$ 20.87M
Total AssetsAU$ 12.41MAU$ 6.37MAU$ 2.56MAU$ 12.62MAU$ 21.68M
Total DebtAU$ 10.77MAU$ 811.19KAU$ 250.57KAU$ 74.76KAU$ 126.95K
Net DebtAU$ 319.44KAU$ -3.60MAU$ -1.31MAU$ -11.51MAU$ -20.75M
Total LiabilitiesAU$ 15.47MAU$ 15.89MAU$ 5.14MAU$ 2.56MAU$ 1.18M
Stockholders' EquityAU$ -3.05MAU$ -9.52MAU$ -2.59MAU$ 10.06MAU$ 20.50M
Cash Flow
Free Cash FlowAU$ -20.47MAU$ -13.15MAU$ -12.73MAU$ -9.05MAU$ -7.93M
Operating Cash FlowAU$ -20.44MAU$ -13.01MAU$ -12.69MAU$ -9.01MAU$ -7.86M
Investing Cash FlowAU$ -443.90KAU$ -141.90KAU$ -38.63KAU$ -40.34KAU$ -76.01K
Financing Cash FlowAU$ 26.92MAU$ 16.00MAU$ 2.71MAU$ -240.50KAU$ 26.12M
Currency in AUD

Recce Pharmaceuticals Ltd. Earnings and Revenue History

Recce Pharmaceuticals Ltd. Debt to Assets

Recce Pharmaceuticals Ltd. Cash Flow

Recce Pharmaceuticals Ltd. Forecast EPS vs Actual EPS